These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15076939)

  • 1. Visual outcomes and complications after multiple vitrectomies for diabetic vitreous hemorrhage.
    Cooper B; Shah GK; Grand MG; Bakal J; Sharma S
    Retina; 2004 Feb; 24(1):19-22. PubMed ID: 15076939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral retinal cryotherapy for postvitrectomy diabetic vitreous hemorrhage in phakic eyes.
    Neely KA; Scroggs MW; McCuen BW
    Am J Ophthalmol; 1998 Jul; 126(1):82-90. PubMed ID: 9683153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage.
    Chaudhry NA; Lim ES; Saito Y; Mieler WF; Liggett PE; Filatov V
    Ophthalmology; 1995 Aug; 102(8):1164-9. PubMed ID: 9097742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
    Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
    Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage.
    Cheema RA; Mushtaq J; Al-Khars W; Al-Askar E; Cheema MA
    Retina; 2010; 30(10):1646-50. PubMed ID: 20634777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
    Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
    Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results, prognostic factors and cataract surgery after diabetic vitrectomy: a 10-year follow-up study.
    Ostri C; Lux A; Lund-Andersen H; la Cour M
    Acta Ophthalmol; 2014 Sep; 92(6):571-6. PubMed ID: 24373516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of vitreous surgery for proliferative diabetic retinopathy.
    Sima P; Zoran T
    Doc Ophthalmol; 1994; 87(3):223-32. PubMed ID: 7835192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitrectomy for complications of proliferative diabetic retinopathy. Functional outcomes.
    Smiddy WE; Feuer W; Irvine WD; Flynn HW; Blankenship GW
    Ophthalmology; 1995 Nov; 102(11):1688-95. PubMed ID: 9098263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin).
    Lo WR; Kim SJ; Aaberg TM; Bergstrom C; Srivastava SK; Yan J; Martin DF; Hubbard GB
    Retina; 2009; 29(7):926-31. PubMed ID: 19584650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
    Brown JS; Mahmoud TH
    Retina; 2011 Nov; 31(10):1983-7. PubMed ID: 21836531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term visual and retinopathy outcomes in a predominately type 2 diabetic patient population undergoing early vitrectomy and endolaser for severe vitreous haemorrhage.
    Ratnarajan G; Mellington F; Saldanha M; de Silva SR; Benjamin L
    Eye (Lond); 2011 Jun; 25(6):704-8; quiz 709. PubMed ID: 21494282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
    Lee BJ; Yu HG
    Retina; 2010; 30(10):1671-7. PubMed ID: 21060273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual Outcomes after Vitrectomy for Terson Syndrome Secondary to Traumatic Brain Injury.
    Narayanan R; Taylor SC; Nayaka A; Deshpande R; St Aubin D; Hrisomalos FN; Hu J; Rajagopal R; Tewari A; Apte RS
    Ophthalmology; 2017 Jan; 124(1):118-122. PubMed ID: 27817917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of different measurements of the preoperative visual acuity and perception of Purkinje's vessel shadows for prediction of the postoperative visual acuity after vitrectomy in diabetic vitreous hemorrhage].
    Schulze S; Köhler K; Schüller C
    Klin Monbl Augenheilkd; 2006 Apr; 223(4):321-5. PubMed ID: 16639671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 10-Hz flash visual evoked potentials in prediction of final visual acuity in diabetic eyes with vitreous hemorrhage.
    Vadrevu VL; Cavender S; Odom JV
    Doc Ophthalmol; 1992; 79(4):371-82. PubMed ID: 1633747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transconjunctival anterior retinal cryotherapy for proliferative diabetic retinopathy.
    Benedett R; Olk RJ; Arribas NP; Okun E; Johnston GP; Boniuk I; Escoffery RF; Grand MG; Schoch LH
    Ophthalmology; 1987 Jun; 94(6):612-9. PubMed ID: 2442689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative electroretinogram and postoperative visual outcome in patients with diabetic vitreous hemorrhage.
    Hiraiwa T; Horio N; Terasaki H; Suzuki T; Yamamoto E; Horiguchi M; Miyake Y
    Jpn J Ophthalmol; 2003; 47(3):307-11. PubMed ID: 12782170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.
    Mason JO; Colagross CT; Haleman T; Fuller JJ; White MF; Feist RM; Emond TL; McGwin G
    Am J Ophthalmol; 2005 Aug; 140(2):231-5. PubMed ID: 15992755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative injection of intravitreal bevacizumab in dense diabetic vitreous hemorrhage.
    Farahvash MS; Majidi AR; Roohipoor R; Ghassemi F
    Retina; 2011; 31(7):1254-60. PubMed ID: 21499192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.